PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 205 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $148,000 | -78.5% | 17,582 | -77.7% | 0.01% | -47.1% |
| Q4 2019 | $689,000 | +282.8% | 78,688 | +454.1% | 0.02% | +183.3% |
| Q2 2019 | $180,000 | -53.6% | 14,200 | +42.0% | 0.01% | -53.8% |
| Q1 2019 | $388,000 | -53.1% | 10,000 | -75.4% | 0.01% | -59.4% |
| Q4 2018 | $827,000 | +240.3% | 40,654 | +667.1% | 0.03% | +190.9% |
| Q3 2018 | $243,000 | +17.4% | 5,300 | +51.4% | 0.01% | 0.0% |
| Q2 2018 | $207,000 | -89.4% | 3,500 | -78.6% | 0.01% | -93.9% |
| Q3 2017 | $1,960,000 | +580.6% | 16,365 | +395.9% | 0.18% | +496.7% |
| Q2 2017 | $288,000 | -76.9% | 3,300 | -82.3% | 0.03% | -85.8% |
| Q3 2016 | $1,247,000 | – | 18,596 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |